Ferzin Sethna

Ferzin Sethna is a Principal Scientist and Group Lead at Asklepios BioPharmaceutical, Inc. (AskBio) since June 2021, previously serving as a Senior Scientist in Product Development. Prior experience includes working as a Principal Scientist in Vector Engineering/Translational Sciences at SwanBio Therapeutics, where responsibilities encompassed designing rodent studies for AAV gene therapy and leading the SBT201 program. Earlier roles include a Research Scientist at Princeton University, where Ferzin collaborated on gene expression constructs and viral vectors, and postdoctoral positions at the Perelman School of Medicine at the University of Pennsylvania and Michigan State University. The academic background includes a Ph.D. in Genetics and Neuroscience from Michigan State University, an MSc in Biochemistry from The Maharaja Sayajirao University of Baroda, and a BSc in Life Sciences and Biochemistry from St. Xavier's College.